LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!


   Articles with "non switchers" as a keyword



Switching from originator infliximab to biosimilar versus continuing on originator in inflammatory bowel disease: results from the observational Project NORTH study

Sign Up to like & get
recommendations! Published in 2022 at "Scandinavian Journal of Gastroenterology"

DOI: 10.1080/00365521.2022.2090275

Abstract: Abstract Objective Project NORTH compared real-world clinical and economic outcomes in Swedish patients with inflammatory bowel disease (IBD) who switched from originator infliximab to its biosimilar. Materials and methods Data from electronic medical records and… read more here.

Keywords: disease; non switchers; originator infliximab; infliximab biosimilar ... See more keywords

Persistence and adherence with Latanoprost: A Danish register-based cohort study in older patients with glaucoma.

Sign Up to like & get
recommendations! Published in 2023 at "Acta ophthalmologica"

DOI: 10.1111/aos.15715

Abstract: PURPOSE This study aims to assess the association between switching patterns and adherence/persistence in Danish patients over the age of 65, who started their first-ever glaucoma treatment with latanoprost eye drops. METHODS Patients were assigned… read more here.

Keywords: adherence; non switchers; persistence adherence; study ... See more keywords

Generic substitution of amlodipine is not associated with increased risk of mortality or adverse cardiovascular events: An observational cohort study

Sign Up to like & get
recommendations! Published in 2024 at "Clinical and Translational Science"

DOI: 10.1111/cts.13779

Abstract: This study aims to assess clinical outcomes following switching from originator to generic amlodipine. This population‐based, matched, cohort study included users of originator amlodipine using claims data during 2018–2020 from a health system in Tianjin,… read more here.

Keywords: pure switchers; non switchers; cardiovascular events; study ... See more keywords

Timing of tyrosine kinase inhibitor switching and long-term outcomes in chronic myeloid leukemia: A real-world comparative study

Sign Up to like & get
recommendations! Published in 2025 at "Blood"

DOI: 10.1182/blood-2025-7945

Abstract: Background: In chronic myeloid leukemia (CML), switching tyrosine kinase inhibitors (TKIs) is often necessary due to intolerance, inadequate response, or resistance. However, the timing of such modifications—whether early after initiation or delayed—may significantly influence long-term… read more here.

Keywords: long term; mortality; tyrosine kinase; non switchers ... See more keywords